JPMA to Consider Information Disclosure on Provision of Labor to Research Institutes in Response to Diovan Scandal

Osamu Inagaki, Head of Drug Evaluation Committee Industry-wide efforts must be made to consider information disclosure on the provision of labor, said Osamu Inagaki, head of the Drug Evaluation Committee of the Japan Pharmaceutical Manufacturers Association (JPMA), at a symposium...read more